Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: Influence of age and marital status

International Journal of Impotence Research

Volumn 21, Issue 5, 2009, Pages 285-291

  Shabsigh, R ^a   Broderick, G A ^b   Althof, S ^c   Natanegara, F ^d   Wong, D G ^e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b MAYO CLINIC   (United States)

^c Center for Marital and Sexual Health of South Florida   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e Lilly USA   (United States)

Author keywords

Duration of effectiveness; Erectile dysfunction; Sexual behavior; Tadalafil; Timing of intercourse attempts

Indexed keywords

TADALAFIL;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT SATISFACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEXUAL INTERCOURSE; TREATMENT DURATION; TREATMENT WITHDRAWAL;

ADULT; AGED; AGING; CARBOLINES; COITUS; ERECTILE DYSFUNCTION; FEMALE; HUMANS; MALE; MARITAL STATUS; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70349202376     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2009.24     Document Type: Article

References (19)

1. NIH Consensus Conference. Impotence NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83-90.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
3. Furlow WL. Prevalence of impotence in the United States. Med Aspects Hum Sex 1985; 19: 13-164.
4. Lue TF. Erectile dysfunction. N Engl J Med 2000; 342: 1802-1813.
5. Althof SE, O'Leary MP, Cappelleri JC, Crowley AR, Tseng LJ, Collins S. Impact of erectile dysfunction on confidence, self-esteem and relationship satisfaction after 9 months of sildenafil citrate treatment. J Urol 2006; 176: 2132-2137.
6. Wagner G, Fugl-Meyer KS, Fugl-Meyer AR. Impact of erectile dysfunction on quality of life: patient and partner perspectives. Int J Impot Res 2000; 12(Suppl 4): S144-S146.
7. Hatzichristou D, Vardi Y, Papp G, Pushkar D, Basson BR, Kopernicky V. Effect of tadalafil on sexual timing behavior patterns in men with erectile dysfunction: integrated analysis of randomized, placebo controlled trials. J Urol 2005; 174: 1356-1359.
8. Rosen R, Broderick G, Shabsigh R, Swindle R, Lockhart D, Cameron A. Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction. J Sex Med 2005; 2: 461-468.
9. Fisher WA, Rosen RC, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005; 2: 675-684.
10. Morgentaler A, Barada J, Niederberger C, Donatucci C, Garcia CS, Natanegara F et al. Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: use of a novel noninferiority study design. J Sex Med 2006; 3: 492-503.
11. Rosen RC, Swindle R, Lockhart D, Cameron A. Psychological and Interpersonal Relationship Scales (PAIRS): a new tool to measure psychological and relationship impacts of ED treatments. Presented at the Fifth Congress of the European Society for Sexual and Impotence Research. 1-4 December 2002; Hamburg, Germany. 2002.
12. Gomery P, Bullock A, McGettigan J, Munarriz R, Natanegara F, Hague J et al. Tadalafil is efficacious in Black American and Hispanic men with erectile dysfunction: results from multiple observations in men with erectile dysfunction in national tadalafil study in the US (MOMENTUS). Int J Impot Res 2007; 19 : 76-83. (Pubitemid 46067352)
13. Moncada I, Damber JE, Mirone V, Wespes E, Casariego J, Chan M et al. Sexual intercourse attempt patterns with two dosing regimens of tadalafil in men with erectile dysfunction: results from the SURE study in 14 European countries. J Sex Med 2005; 2: 668-674. (Pubitemid 41742927)
14. Hanson-Divers C, Jackson SE, Lue TF, Crawford SY, Rosen RC. Health outcomes variables important to patients in the treatment of erectile dysfunction. J Urol 1998; 159: 1541-1547.
15. Shabsigh R, Burnett AL, Eardley I, Sharlip ID, Ellsworth PI, Garcia CS et al. Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials. BJU Int 2005; 96 : 857-863.
16. Dean J, Hackett GI, Gentile V, Pirozzi-Farina F, Rosen RC, Zhao Y et al. A psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study. J Sex Med 2006; 3: 650-661.
17. Del Popolo G, Li Marzi V, Mondaini N, Lombardi G. Time/ duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients. Spinal Cord 2004; 42: 643-648.
18. Cappelleri JC, Bell SS, Althof SE, Siegel RL, Stecher VJ. Comparison between sildenafil-treated subjects with erectile dysfunction and control subjects on the Self-Esteem and Relationship questionnaire. J Sex Med 2006; 3: 274-282.
19. Fisher WA, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P et al. Improving the sexual quality of life of couples affected by erectile dysfunction: A double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2005; 2: 699-708. (Pubitemid 41742930)